Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection
Hepatitis B surface antigen (HBsAg) has recently gained traction as a biomarker that may provide prognostic information and inform treatment decisions in chronic hepatitis B virus (HBV) infection. It may be particularly useful when HBV DNA levels are low and therefore difficult to quantify accuratel...
Main Authors: | Downs, L, Patel, M, Ansari, M, McNaughton, A, Smith, D, Andersson, M, Barnes, E, Jeffery, K, Matthews, P |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|
Similar Items
-
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
by: Shaowen Jiang, et al.
Published: (2023-01-01) -
Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01) -
Electronic health informatics data to describe clearance dynamics of hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) in chronic hepatitis B virus infection
by: Downs, L, et al.
Published: (2019) -
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
by: Ekta Gupta, et al.
Published: (2023-12-01) -
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)